Clinical trials okayed for children with 'bubble boy' disease - Capitol Weekly - News Summed Up

Clinical trials okayed for children with 'bubble boy' disease - Capitol Weekly


The therapy originated at UCLA with the help of more than $40 million from the California stem cell agency. (Capitol Weekly was the first to disclose on May 11, 2021, the impact of Orchard’s decision to drop the therapy.). The therapy originated at UCLA with the help of more than $40 million from the California stem cell agency. The three are expected to be enrolled in the trial next month, Steve Peckman, deputy director of the UCLA Broad Stem Cell Research Center, told Capitol Weekly today. Geron has since sold off its human stem cell research assets and today is a much different company.


Source: Los Angeles Times December 04, 2022 22:10 UTC



Loading...
Loading...
  

Loading...